2min chapter

The HemOnc Pulse cover image

Dr. Usmani Discusses Perseus, IsKia, Data Plus More Myeloma Updates

The HemOnc Pulse

CHAPTER

Discussion on Venetoclax Data and Personalizing Therapy for Translocation 1114 Myeloma

Discussion of clinical abstracts presented at the conference focusing on the data of a combination treatment of Venetoclax, Deratumumab, and dexamethasone for translocation 1114 disease, with a high overall response rate and complete response rate. Emphasis on personalizing therapy, excitement about long-term follow-up data, and frustration about the delay in biomarker-driven treatments.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode